(Q37475459)

20 August 2017

Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? (English)

1 reference

20 August 2017

United States of America

0 references

author name string

Ashraf S Ibrahim

1

1 reference

20 August 2017

John E Edwards

2

1 reference

20 August 2017

Richard Bryant

3

1 reference

20 August 2017

Brad Spellberg

4

1 reference

20 August 2017

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

47

1 reference

20 August 2017

6

1 reference

20 August 2017

592-600

1 reference

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Overview of the diagnosis and management of diabetic ketoacidosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Zygomycosis (mucormycosis): emerging clinical importance and new treatments

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Improved outcome of zygomycosis in patients with hematological diseases?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Zygomycetes in human disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Diabetic ketoacidosis in Denmark Incidence and mortality estimated from public health registries.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Childhood type 1 diabetes mellitus in Newfoundland and Labrador, Canada.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2793326

Genetic damage following introduction of DNA in Phycomyces.

2 September 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Haemophilus influenzae type b immunization in adults infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus–Infected Patients: A Double‐Blind, Randomized, Placebo‐Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Pneumonia in HIV-infected patients: a case-control survey of factors involved in risk and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Interpreting vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Hepatitis A and B Vaccination Practices for Ambulatory Patients Infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13693780802326001

Prospects for and barriers to a fungal vaccine

21 January 2018

1 reference

12 December 2020

Zygomycosis in the 1990s in a tertiary-care cancer center

1 reference

12 December 2020

Product development plan for new vaccine technologies

1 reference

12 December 2020

Quality-adjusted survival in the first year after the acute respiratory distress syndrome

1 reference

12 December 2020

An economic evaluation of activated protein C treatment for severe sepsis

1 reference

12 December 2020

10.1080/13693780802326001

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

18798118

1 reference